Isoniazid
Isoniazid, also known as isonicotinic acid hydrazide (INH), is an antibiotic used for the treatment of tuberculosis. For active tuberculosis, it is often used together with rifampicin, pyrazinamide, and either streptomycin or ethambutol. For latent tuberculosis, it is often used alone. It may also be used for atypical types of mycobacteria, such as M. avium, M. kansasii, and M. xenopi. It is usually taken by mouth, but may be used by injection into muscle.
Clinical data | |
---|---|
Trade names | Hydra, Hyzyd, Isovit, others |
Other names | isonicotinic acid hydrazide, isonicotinyl hydrazine, INH, INAH, INHA |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682401 |
License data | |
Pregnancy category |
|
Routes of administration | By mouth, intramuscular, intravenous |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Protein binding | Very low (0–10%) |
Metabolism | liver; CYP450: 2C19, 3A4 inhibitor |
Elimination half-life | 0.5–1.6h (fast acetylators), 2-5h (slow acetylators) |
Excretion | urine (primarily), feces |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
NIAID ChemDB | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.195 |
Chemical and physical data | |
Formula | C6H7N3O |
Molar mass | 137.142 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
| |
(verify) |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.